Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Early research (Phase 1)UnknownNCT04107142
What this trial is testing

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10
Early research (Phase 1)Looking for participantsNCT07543055
What this trial is testing

BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

Who this might be right for
Prostate Cancer
Regeneron Pharmaceuticals 36
Not applicableLooking for participantsNCT05366881
What this trial is testing

CfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Who this might be right for
Brain CancerBreast CancerBladder Cancer+17 more
Adela, Inc 7,000
Testing effectiveness (Phase 2)Study completedNCT00283803
What this trial is testing

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 32
Testing effectiveness (Phase 2)Temporarily pausedNCT00127088
What this trial is testing

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris 37
Early research (Phase 1)Study completedNCT04701021
What this trial is testing

TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

Who this might be right for
Prostate Cancer
Ultimovacs ASA 12
Not applicableStudy completedNCT03421015
What this trial is testing

Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution

Who this might be right for
Prostatic Neoplasms
University Hospital, Lille 84
Testing effectiveness (Phase 2)Study completedNCT00071968
What this trial is testing

Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT05036226
What this trial is testing

COAST Therapy in Advanced Solid Tumors and Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentSolid Tumor, Adult
Medical University of South Carolina 76
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Large-scale testing (Phase 3)Study completedNCT01272050
What this trial is testing

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 350
Early research (Phase 1)Study completedNCT05159518
What this trial is testing

PRT2527 in Participants With Advanced Solid Tumors

Who this might be right for
SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more
Prelude Therapeutics Incorporated 30
Early research (Phase 1)Ended earlyNCT00313534
What this trial is testing

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 15
Not applicableStudy completedNCT04247217
What this trial is testing

Immune Profiling After HDR in Local Relapsed Prostate Cancer

Who this might be right for
Prostate CancerPD-L1
Maastricht Radiation Oncology 10
Not applicableStudy completedNCT00235794
What this trial is testing

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Who this might be right for
Prostatic Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT00241475
What this trial is testing

Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy

Who this might be right for
Prostate Cancer
AstraZeneca 30
Testing effectiveness (Phase 2)Ended earlyNCT02769962
What this trial is testing

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Urothelial CarcinomaUrothelial CancerLung Neoplasms+2 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00223665
What this trial is testing

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 102
Large-scale testing (Phase 3)Active Not RecruitingNCT04181203
What this trial is testing

Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy

Who this might be right for
Prostate Cancer
UNICANCER 490
Next Page